Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France.
Laurent BertolettiGaelle GustoArtak KhachatryanNadia QuignotJose ChavesAudrey MoniotRuth MokgokongPublished in: Thrombosis and haemostasis (2022)
Apixaban was associated with superior safety and effectiveness than VKAs. All-cause mortality was lower in both DOACs than VKAs. Our results support recommendations to use DOACs over VKAs for the treatment of VTE.